UnitedHealth Group (UNH) director awarded 16 dividend-equivalent shares

Rhea-AI Filing Summary

UnitedHealth Group director Paul R. Garcia received an equity-based award linked to existing deferred stock units. On March 17, 2026, he acquired 16 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units that are immediately vested and subject to the same terms as the underlying units.

Following this grant, Garcia directly holds 3,330 shares of UnitedHealth Group common stock. He also has indirect holdings reported through a revocable trust and additional trusts, reflecting shares held in estate-planning vehicles rather than through open‑market transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GARCIA PAUL R

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		A		16(1)	A	$0	3,330	D
Common Stock								2,146	I	By Revocable Trust
Common Stock								45	I	By Trust 2
Common Stock								55	I	By Trust 3

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Paul R. Garcia	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did UnitedHealth Group (UNH) director Paul R. Garcia report in this Form 4?

Paul R. Garcia reported receiving 16 UnitedHealth Group common shares as a dividend-equivalent grant on vested deferred stock units. The shares are immediately vested and follow the same terms as the underlying deferred stock units, reflecting a compensation-related equity award rather than an open-market trade.

How many UnitedHealth Group (UNH) shares does Paul R. Garcia hold directly after this filing?

After the reported grant, Paul R. Garcia directly holds 3,330 shares of UnitedHealth Group common stock. This figure reflects his direct ownership position as of the transaction date and does not include additional shares held indirectly through various trusts noted in the Form 4.

What is the nature of the 16-share award reported by Paul R. Garcia for UNH?

The 16-share award represents dividend equivalents paid on vested deferred stock units for UnitedHealth Group. These dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units, classifying the transaction as a compensation-related grant rather than a market purchase.

Did Paul R. Garcia buy or sell UnitedHealth Group (UNH) shares on the open market?

The Form 4 does not show any open-market purchases or sales by Paul R. Garcia. Instead, it records an acquisition coded as a grant or award of 16 shares, stemming from dividend equivalents on vested deferred stock units, which is a non-cash compensation event.

What indirect UnitedHealth Group (UNH) holdings are reported for Paul R. Garcia?

The filing shows indirect holdings for Paul R. Garcia through a revocable trust and two additional trusts. These indirect entries list post-transaction share balances for each trust, indicating that some UnitedHealth Group shares are held in trust structures rather than solely in his personal direct account.

Does this UnitedHealth Group (UNH) Form 4 show any derivative securities for Paul R. Garcia?

The derivative section in this Form 4 is empty for Paul R. Garcia, indicating no derivative securities such as options or similar instruments are reported in this particular filing. The transactions disclosed relate only to common stock and dividend-equivalent grants tied to existing deferred stock units.